Slide Presentations: TVT 2014
Neurovascular Updates from TVT 2014
Why Cerebral Protection after TAVR Will be Used Sparingly (if at all) in the Future
Ganesh Manoharan
Perspectives from the US CoreValve Trials
Jeffrey Popma
Perspectives from the PARTNER Trials
Susheel Kodali
Incidence, Timing, Predictors (New Onset AF, Postdilatation, etc.), and Clinical Impact
Samir Kapadia
Has Stroke Frequency Declined After TAVR?
Nicolas van Mieghem